Literature DB >> 16792825

Screening for breast cancer in England: past and future.

.   

Abstract

The NHS Breast Screening Programme (NHSBSP) began in 1988. It aims to invite all women aged 50-70 years for mammographic screening once every three years. The programme now screens 1.3 million women each year, about 75% of those invited, and diagnoses about 10,000 breast cancers annually. Although some have questioned the value of screening for breast cancer, the scientific evidence demonstrates clearly that regular mammographic screening between the ages of 50 and 70 years reduces mortality from the malignancy. Screened women are slightly more likely than unscreened women to be diagnosed with breast cancer. The cancers in screened women are smaller and are less likely to be treated with mastectomy than they would have been if diagnosed without screening. For every 400 women screened regularly by the NHSBSP over a 10-year period, one woman fewer will die from breast cancer than would have died without screening. The current NHSBSP saves an estimated 1400 lives each year in England. The screening programme spends about pound sterling 3000 for every year of life saved.

Entities:  

Mesh:

Year:  2006        PMID: 16792825     DOI: 10.1258/096914106777589678

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  19 in total

Review 1.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

Review 2.  Breast screening review--a radiologist's perspective.

Authors:  M J Michell
Journal:  Br J Radiol       Date:  2012-07       Impact factor: 3.039

3.  Who evaluates public health programmes? A review of the NHS Breast Screening Programme.

Authors:  Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  J R Soc Med       Date:  2010-01       Impact factor: 5.344

Review 4.  Review of radiological screening programmes for breast, lung and pancreatic malignancy.

Authors:  Helena Barton; David Shatti; Charlotte Anne Jones; Mathuri Sakthithasan; Will W Loughborough
Journal:  Quant Imaging Med Surg       Date:  2018-06

5.  Breast cancer screening outreach effectiveness: Mammogram-specific reminders vs. comprehensive preventive services birthday letters.

Authors:  Diana S M Buist; Hongyuan Gao; Melissa L Anderson; Tracy Onega; Susan Brandzel; Melissa A Rabelhofer; Susan Carol Bradford; Erin J Aiello Bowles
Journal:  Prev Med       Date:  2017-06-24       Impact factor: 4.018

6.  The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004.

Authors:  Yien Ning S Wong; Ruth H Jack; Vivian Mak; Møller Henrik; Elizabeth A Davies
Journal:  BMC Cancer       Date:  2009-06-29       Impact factor: 4.430

7.  Histopathology of women with non-uniform endometrial echogenicity and risk factors for atypical endometrial hyperplasia and carcinoma.

Authors:  Qing Cong; Lingxiao Luo; Zhongpeng Fu; Jiaqi Lu; Wei Jiang; Long Sui
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

8.  Do women know that the risk of breast cancer increases with age?

Authors:  Kath Moser; Julietta Patnick; Valerie Beral
Journal:  Br J Gen Pract       Date:  2007-05       Impact factor: 5.386

9.  Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.

Authors:  R L Bennett; S J Sellars; S M Moss
Journal:  Br J Cancer       Date:  2011-02-01       Impact factor: 7.640

10.  Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England.

Authors:  Stephen W Duffy; Laszlo Tabar; Anne Helene Olsen; Bedrich Vitak; Prue C Allgood; Tony H H Chen; Amy M F Yen; Robert A Smith
Journal:  J Med Screen       Date:  2010       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.